HomeTherapeutic areasRespiratory › Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (3 companies)

Companies with an active program in Idiopathic Pulmonary Fibrosis.

Ticker Company Therapeutic areas Programs Lead stage Programs
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
RVPH Reviva Pharmaceuticals CardiovascularDermatology+2 Rare 1 Phase 3 10
GPCR Structure Therapeutics MetabolicRespiratory Rare 1 Phase 2 5